Drawing for ELION

USPTO serial 87219813

ELION

Reviewed by CopyMark Law Group

Reg. 5217912Status 710
Filing date
Status date
Registration date
Jun 6, 2017
Examiner
BUSH, KAREN K
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ELION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Terrence M.. Wyles,

TERRENCE M.. WYLES, STARTUP IP LAW, LLC2404 S. OAKLAND CIR.AURORA, CO 80014UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Regulatory submission management, namely, assisting others in preparing and filing applications for biologics license applications with governmental regulatory bodiesSECTION 8 - CANCELLEDAug 24, 2015
042Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Laboratory research services relating to pharmaceuticals; Laboratory research in the field of biopharmaceutical characterization; Scientific laboratory services; Scientific and technological services, namely, analytical testing of biopharmaceuticals in the field of pharmaceutical biotechnology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogeneticsSECTION 8 - CANCELLEDAug 24, 2015
045Regulatory compliance consulting in the field of chemistry manufacturing and controls (CMC) regulatory submissionsSECTION 8 - CANCELLEDAug 24, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 22, 2023C8..CANCELLED SEC. 8 (6-YR)—
Jun 6, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 6, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 7, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 7, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 7, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 7, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 7, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 6, 2017DOCKASSIGNED TO EXAMINER—
Nov 3, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Nov 2, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance